Don’t Let Your PI Walk Away With Your Study

 In this tactical masterclass, Darshan Kulkarni breaks down the critical legal architecture required to protect clinical trial sites during rapid expansion. As PIs and Sub-Investigators move between organizations, the risk of losing proprietary data and patient continuity skyrockets. Learn the specific clauses—from non-solicitation to transition requirements—that ensure your site retains its value and your sponsors remain confident. Don't let your most valuable assets walk out the door; learn how to lock down your contracts today. 

Transcript

Darshan 0:00

How do I keep PI and sub-I contracts straight so that they don't walk away with patients or data? This has been coming up for me more often as sites are spending more time expanding. Now your PI agreement should clearly outline obligations, whether we're talking about oversight, reporting, patient safety, delegation. Sub-investigator contracts must reinforce that data, patience, and study materials belong to the site and not the individual. Otherwise, sub-eyes and PIs can leave and take their patients with them. Include non-solicitation and confidentiality provisions, because this may or may not be enforceable within your state's law. You must see whether they are applicable. Spell out that any patient recruited under the trial is retained by the site even if the investigator departs. If possible, build in transition clauses that require cooperation during staff turnover. Strong PI and sub I agreements prevent data loss. They protect patient continuity, and they keep sponsors confident in your stability. Call, click, or email.